Sarcoma and GIST 2008

TITLE	SESSION	AUTHOR
Pathology of desmoid fibromatosis	Borderline/ low-grade sarcomas	A. Franchi
Radiation therapy vis-a-vis biology	Borderline/ low-grade sarcomas	M. Robinson
The clinic od sporadic and syndromic desmoid fibromatosis	Borderline/ low-grade sarcomas	J. Martin
The WNT signalling pathway	Borderline/ low-grade sarcomas	D. De Gorter
The clinic of sarcomas with epithelioid morphology	Epithelioid neoplasms	A. Wagner
Delivering treatment: dose intensitiy and dose density?	GIST	A. Le Cesne
Delivering treatment: pharmacology-driven therapy?	GIST	S. Sleijfer
High throughout put oncogene mutation profiling	GIST	M. Loda
Molecular biology of GIST	GIST	E. Tamborini
Natural history and standard treatment of GIST	GIST	P. Reichardt
New avenues in GIST treatment	GIST	G. Demetri
Pathology of GIST	GIST	P. Hogendoorn
Resistance to TKI: KIT and PDGFRA	GIST	M. Debiec-Rychter
State-of-the-art tumor response assessment (at least in GIST)	GIST	R. Benjamin
Surgery of residual disease	GIST	A. Gronchi
Gene profiling to find targets	Other today-targetable sarcomas	M. Van de Rijn
Genetics of well differentiated/dedifferentiated liposarcoma	Other today-targetable sarcomas	F. Pedeutour
How to select a target in sarcoma	Other today-targetable sarcomas	M. von Mehren
Non mutational alterations of RTKs	Other today-targetable sarcomas	S. Pilotti
Targeting angiogenesis in sarcoma	Other today-targetable sarcomas	R. Maky